Navigation Links
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
Date:5/17/2012

tudy design, please visit www.clinicaltrials.gov (NCT01041859).

Janssen Research & Development, LLC  and Grunenthal GmbH, conducted this study, which Janssen Research & Development, LLC has included as part of its Supplemental New Drug Application (sNDA) submitted on October 28, 2011 to the U.S. Food and Drug Administration (FDA) for tapentadol ER tablets for the management of neuropathic pain associated with DPN in patients 18 years of age or older. The FDA currently is reviewing this supplemental application.

About Tapentadol and NUCYNTA® ER

Tapentadol is a centrally-acting synthetic analgesic. The tapentadol molecule is classified as Schedule II of the Controlled Substances Act.

NUCYNTA® ER (tapentadol) extended-release tablets are an oral analgesic available by prescription only and indicated for the management of moderate to severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. NUCYNTA® ER is taken twice daily and available in 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths.

Outside the United States, tapentadol is marketed by Janssen Inc. in Canada; Grünenthal GmbH discovered tapentadol and markets immediate- and extended-release formulations of tapentadol (PALEXIA®) in various countries in Europe.

IMPORTANT SAFETY INFORMATION FOR NUCYNTA® ER (tapentadol) extended-release tablets

WARNING: POTENTIAL FOR ABUSE, PROPER PATIENT SELECTION, AND LIMITATIONS OF USE

Potential for Abuse

NUCYNTA® ER contains tapentadol, a mu-opioid agonist and a Schedule II controlled substance with an abus
'/>"/>

SOURCE Janssen Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
2. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
3. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
4. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
5. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
6. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
7. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
10. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching our shared ... CONTACTS announces their new Apple Watch app which allows the ... Two taps. New contacts. From your watch. We live ... LensGauge which helps keep track of how long your lenses ... "Since our inception, we,ve been dedicated to providing our ...
(Date:4/24/2015)... , April 24, 2015  Bayer Corporation hosted its ... 23 at the Bayer HealthCare US headquarters.  This is Bayer,s ... the Whippany campus, and Thursday,s event ... do every day at work. Fortunately, for the ... As a company whose mission is "Science For A Better ...
(Date:4/24/2015)... April 24, 2015 In today,s ever-changing ... groups around the world to access diverse skill ... While there are many areas to misstep in ... which best practices are necessary and beneficial in ... According to research by benchmarking firm, Best ...
Breaking Medicine Technology:Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2
... 1, 2011 Please replace the release dated August ... second and third sentences added and should read: The ... will be filed in a Form 8K with the ... on Friday, September 9, 2011.  This presentation will also ...
... 1, 2011 GeoVax Labs, Inc. (OTCQB/OTCBB: ... and fight Human Immunodeficiency Virus (HIV) infections, today announced ... to $4.4 million for its Integrated Preclinical/Clinical AIDS Vaccine ... This five-year grant was originally awarded in 2007 ...
Cached Medicine Technology:UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September 2UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September 3GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government 2GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government 3
(Date:4/26/2015)... Orlando, FL (PRWEB) April 26, 2015 ... States, pioneered in delivering valuable community services to the ... several developmental projects in India for more than two ... served hundreds and thousands of subscribers around the world ... such source at that time. The Immigration Law Forum ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 Forbes Living ... The city is one which is synonymous with clean beaches, ... trade, and education are major economic influencers in the city ... the dynamic talk show are pleased to announce the show ... April 26 at 3:00 PM PDT. Tune in to find ...
(Date:4/25/2015)... 2015 The National League for ... national endeavor to prepare nurses to provide high quality, ... success, according to a new report by the John ... partners. , The project began in 2007 as ... the direction of Elaine Tagliareni, EdD, RN, CNE, FAAN, ...
(Date:4/25/2015)... D.C. (PRWEB) April 25, 2015 In ... worldwide will join The Million Nets Pledge, a two-year ... campaign to protect refugee families with one million bednets ... their increased work with UN partners to protect children, ... from malaria. , “There has been a large ...
(Date:4/25/2015)... York (PRWEB) April 25, 2015 ... for vaginal mesh lawsuits filed against C.R. Bard, ... District Court, Southern District of West Virginia. According ... Scheduling Conference was convened that day, after certain ... Long Form Complaint. The Order directed that any ...
Breaking Medicine News(10 mins):Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4
... , CINCINNATI, Dec. 8, 2009 ... ) today announced the appointment of Angela F. Braly ... (NYSE: WLP ), to its board of ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091208/CL22979-a ) , (Photo: ...
... Registration is open for the 2010 AIUM Annual Convention ... the United States dedicated to all disciplines of medical ... Diego, California. The 2010 Annual Convention focuses on emerging ... scientists, and manufacturers as ultrasound continues to advance and ...
... Scripps Research Institute have determined the structure of a critical ... of the deadliest viruses on the planet killing between 50 ... online Early Edition of the journal Proceedings of the ... reveals how a key component of the Ebola virus, called ...
... could lead to better diagnoses, experts say , TUESDAY, Dec. ... as it beats, and a German study shows how the ... and old. , In the study, published in the Dec. ... at University Hospital Freiburg describe the different heartbeats they saw ...
... high-flow oxygen treatment , TUESDAY, Dec. 8 (HealthDay ... treatment for cluster headaches, British researchers have found. , ... eight per day in bouts that last for weeks ... drug sumatriptan, but frequent use of the drug isn,t ...
... not aggression, researchers say, , TUESDAY, Dec. 8 (HealthDay ... male sex hormone actually encourages a sense of fair ... cause aggression, said lead researcher Michael Naef, of the ... But it does lead to "status-seeking behavior -- or ...
Cached Medicine News:Health News:Procter & Gamble Announces Appointment of Director 2Health News:AIUM gears up for 2010 Annual Convention in San Diego, California 2Health News:Scripps Research scientists reveal key structure from ebola virus 2Health News:Beating Heart Differs by Gender, Age: Study 2Health News:Oxygen Therapy May Relieve Cluster Headache Pain 2Health News:Testosterone Gets Bad Rap: Study 2Health News:Testosterone Gets Bad Rap: Study 3
Athouritative, on the spot answers for acute care and consultations....
... The SphygmoCor Mx Central Blood Pressure ... the SphygmoCor Px system by providing ... pressure waveform., ,Key cardiovascular parameters are ... These parameters include:, Central Systolic, ...
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Medicine Products: